SMTL ID : 4bpm.1

Crystal structure of a human integral membrane enzyme

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.08 Å

Oligo State

homo-trimer

Ligands

3 x GSH: GLUTATHIONE(Non-covalent)

GSH.1: 14 residues within 4Å: Chain A: R.68, R.71, N.72, E.75, H.111, Y.115, R.124, S.125, Y.128 Chain C: A.29, T.32, R.36, L.67 Ligands: LVJ.2 13 PLIP interactions: 4 interactions with chain C, 9 interactions with chain A Hydrophobic interactions: C:T.32 Water bridges: C:R.36, C:H.70, A:Y.128 Salt bridges: C:R.36, A:R.71, A:R.71 Hydrogen bonds: A:R.71, A:N.72, A:E.75, A:Y.115, A:Y.115, A:R.124 GSH.3: 14 residues within 4Å: Chain A: A.29, T.32, R.36, L.67 Chain B: R.68, R.71, N.72, E.75, H.111, Y.115, R.124, S.125, Y.128 Ligands: LVJ.4 13 PLIP interactions: 9 interactions with chain B, 4 interactions with chain A Hydrogen bonds: B:R.71, B:N.72, B:E.75, B:Y.115, B:Y.115, B:R.124 Water bridges: B:Y.128, A:R.36, A:H.70 Salt bridges: B:R.71, B:R.71, A:R.36 Hydrophobic interactions: A:T.32 GSH.5: 14 residues within 4Å: Chain B: A.29, T.32, R.36, L.67 Chain C: R.68, R.71, N.72, E.75, H.111, Y.115, R.124, S.125, Y.128 Ligands: LVJ.6 13 PLIP interactions: 9 interactions with chain C, 4 interactions with chain B Hydrogen bonds: C:R.71, C:N.72, C:E.75, C:Y.115, C:Y.115, C:R.124 Water bridges: C:Y.128, B:R.36, B:H.70 Salt bridges: C:R.71, C:R.71, B:R.36 Hydrophobic interactions: B:T.32

3 x LVJ: 2-[[2,6-bis(chloranyl)-3-[(2,2-dimethylpropanoylamino)methyl]phenyl]amino]-1-methyl-6-(2-methyl-2-oxidanyl-propoxy)-N-[2,2,2-tris(fluoranyl)ethyl]benzimidazole-5-carboxamide(Non-covalent)

LVJ.2: 15 residues within 4Å: Chain A: A.121, P.122, S.125, V.126, Y.128, T.129, L.130 Chain C: G.33, Q.34, L.37, F.42, D.47, R.50, H.51 Ligands: GSH.1 9 PLIP interactions: 4 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:F.42, C:D.47, A:V.126, A:Y.128 Hydrogen bonds: C:Q.34, C:H.51, A:S.125, A:T.129 Halogen bonds: A:V.126 LVJ.4: 15 residues within 4Å: Chain A: G.33, Q.34, L.37, F.42, D.47, R.50, H.51 Chain B: A.121, P.122, S.125, V.126, Y.128, T.129, L.130 Ligands: GSH.3 9 PLIP interactions: 4 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: A:F.42, A:D.47, B:V.126, B:Y.128 Hydrogen bonds: A:Q.34, A:H.51, B:S.125, B:T.129 Halogen bonds: B:V.126 LVJ.6: 15 residues within 4Å: Chain B: G.33, Q.34, L.37, F.42, D.47, R.50, H.51 Chain C: A.121, P.122, S.125, V.126, Y.128, T.129, L.130 Ligands: GSH.5 9 PLIP interactions: 5 interactions with chain C, 4 interactions with chain B Hydrophobic interactions: C:V.126, C:Y.128, B:F.42, B:D.47 Hydrogen bonds: C:S.125, C:T.129, B:Q.34, B:H.51 Halogen bonds: C:V.126

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, D. et al., Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy. Cryst.Growth Des. (2014)

Release Date

2014-04-16

Peptides

PROSTAGLANDIN E SYNTHASE, FUSION PEPTIDE: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

PROSTAGLANDIN E SYNTHASE, FUSION PEPTIDE

Related Entries With Identical Sequence